These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20607219)

  • 21. Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression.
    Wood CM; Wafford KA; McCarthy AP; Hewes N; Shanks E; Lodge D; Robinson ESJ
    Neuropharmacology; 2018 Sep; 140():246-259. PubMed ID: 30005976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal phencyclidine and social isolation in the rat: effects of clozapine on locomotor activity, social recognition, prepulse inhibition, and executive functions deficits.
    Hamieh AM; Babin D; Sablé E; Hernier AM; Castagné V
    Psychopharmacology (Berl); 2021 Feb; 238(2):517-528. PubMed ID: 33169202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.
    Xing B; Han G; Wang MJ; Snyder MA; Gao WJ
    Neuropharmacology; 2018 Jul; 137():359-371. PubMed ID: 29793154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microinjection of the mGluR2/3 agonist, LY379268, into the nucleus accumbens attenuates extinction latencies and the reinstatement of morphine-induced conditioned place preference in rats.
    Baharlouei N; Sarihi A; Moradi M; Zarrabian S; Haghparast A
    Behav Pharmacol; 2018 Aug; 29(5):385-392. PubMed ID: 29462112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.
    Karlsson RM; Tanaka K; Saksida LM; Bussey TJ; Heilig M; Holmes A
    Neuropsychopharmacology; 2009 May; 34(6):1578-89. PubMed ID: 19078949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation.
    Wischhof L; Aho HE; Koch M
    Pharmacol Biochem Behav; 2012 Jul; 102(1):6-12. PubMed ID: 22469865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats.
    Peters J; Kalivas PW
    Psychopharmacology (Berl); 2006 Jun; 186(2):143-9. PubMed ID: 16703399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice.
    Chen HH; Stoker A; Markou A
    Psychopharmacology (Berl); 2010 May; 209(4):343-50. PubMed ID: 20217053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances.
    Chan MH; Tsai YL; Lee MY; Stoker AK; Markou A; Chen HH
    Psychopharmacology (Berl); 2015 Sep; 232(17):3259-68. PubMed ID: 26044619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats.
    Cilia J; Reavill C; Hagan JJ; Jones DN
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):327-37. PubMed ID: 11549233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats.
    Swanson CJ; Schoepp DD
    J Pharmacol Exp Ther; 2002 Dec; 303(3):919-27. PubMed ID: 12438510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of group II metabotropic glutamate receptor modulation on ethanol- and sucrose-seeking and consumption in the rat.
    Windisch KA; Czachowski CL
    Alcohol; 2018 Feb; 66():77-85. PubMed ID: 29220747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression.
    Wischhof L; Koch M
    Psychopharmacology (Berl); 2012 Jan; 219(2):387-400. PubMed ID: 21863235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.
    Grivas V; Markou A; Pitsikas N
    Eur J Pharmacol; 2013 Sep; 715(1-3):105-10. PubMed ID: 23769742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.
    Orlando R; Borro M; Motolese M; Molinaro G; Scaccianoce S; Caruso A; di Nuzzo L; Caraci F; Matrisciano F; Pittaluga A; Mairesse J; Simmaco M; Nisticò R; Monn JA; Nicoletti F
    Neuropharmacology; 2014 Nov; 86():133-44. PubMed ID: 25063582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice.
    Reiner A; Lafferty DC; Wang HB; Del Mar N; Deng YP
    Neurobiol Dis; 2012 Jul; 47(1):75-91. PubMed ID: 22472187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
    Greenslade RG; Mitchell SN
    Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition.
    Schlumberger C; Schäfer D; Barberi C; Morè L; Nagel J; Pietraszek M; Schmidt WJ; Danysz W
    Behav Pharmacol; 2009 Feb; 20(1):56-66. PubMed ID: 19179851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.
    Amitai N; Markou A
    Eur J Pharmacol; 2010 Aug; 639(1-3):67-80. PubMed ID: 20371228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.